High Likelihood of Accepting COVID-19 Vaccine in a Latinx Community at High SARS-CoV-2 Risk in San Francisco

James Peng; Carina Marquez; Luis Rubio; Gabriel Chamie; Diane Jones; Jon Jacobo; Susana Rojas; Susy Rojas; Valerie Tulier-Laiwa; Douglas Black; Jackie Martinez; Genay Pilarowski; Chesa Cox; Joe Derisi; Diane Havlir; Maya Petersen

doi:10.1093/ofid/ofab202

High Likelihood of Accepting COVID-19 Vaccine in a Latinx Community at High SARS-CoV-2 Risk in San Francisco

Open Forum Infect Dis. 2021 Apr 20;8(10):ofab202. doi: 10.1093/ofid/ofab202. eCollection 2021 Oct.

Authors

Affiliations

¹ University of California, San Francisco, San Francisco, California, USA.
² Unidos en Salud, San Francisco, California, USA.
³ Stanford University, Palo Alto, California, USA.
⁴ Chan Zuckerberg Biohub, San Francisco, California, USA.
⁵ University of California, Berkeley, Berkeley, California, USA.

Abstract

Of 4133 persons surveyed at a low-barrier coronavirus disease 2019 (COVID-19) test site with high positivity in an urban Latinx community in January 2021, 86% indicated that they would accept a COVID-19 vaccination. The top reasons for vaccine hesitancy included concerns around side effects and safety and distrust of health care systems.

Keywords: COVID-19; SARS-CoV-2; vaccine acceptance.